Chapter 7

Legal status and access in Canada


How ketamine, psilocybin and MDMA are regulated, and the legal routes to access that exist today.

In progressLast updated September 26, 2026

This chapter is being written. Every chapter is reviewed against the published research before it goes live.

What this chapter will cover

  • Controlled Drugs and Substances Act schedules
  • Ketamine and esketamine prescribing
  • Special Access Program
  • Section 56 exemptions
  • Clinical trials as an access route
  • Provincial frameworks, including Alberta